Personalise healthcare!

The Old Dominion University in Virginia and Regensburg University Medical Center in Germany are jointly organizing an international conference to discuss recent advances and strategic needs in personalised healthcare (pHealth) care and to foster collaboration between industry and academia.

The world’s first installation of Cisco’s telemetry system HealthPresence has...
The world’s first installation of Cisco’s telemetry system HealthPresence has been completed at Aberdeen Royal Infirmary in Scotland.

Personalised health records, wearable sensors, genetically engineered therapies and other emerging technologies are offering unprecedented opportunities for improving healthcare outcomes.

A growing number of citizens desire to be better informed about and empowered with technologies for personal healthcare. Many clinicians and researchers recognize the need for new methodologies in assessing the comparative effectiveness of personalized health technologies.


The conference aims

  1. to explore the potential of new personalized health technologies in supporting self-care and personal health;
  2. to assess the availability of healthcare knowledge, including comparative effectiveness, needed for effective personalized health;
  3. to review commercial opportunities for transatlantic collaborations;
  4. to develop recommendations for best practices in personalized healthcare.


The conference will produce a white paper and a journal special issue which will be edited by members of the scientific program committee. The white paper is intended to be a set of practical recommendations.

For further information and registration:


More on the subject:
Read all latest stories

Related articles


News • GMAI for cancer treatment

Generalist Medical AI: Experts propose legal guardrails

Generalist Medical Artificial Intelligence (GMAI) models pose a significant challenge to current regulatory frameworks. Experts discuss how regulation of these models could work in the future.


News • New-found blood signatures

Multiple sclerosis: subtype discovery opens new ways for personalized therapy

Researchers discovered three distinct immunological endophenotypes of multiple sclerosis, defined by specific blood immune signatures. This opens new avenues for personalized treatment strategies.


News • Personalised oncology

New platform to significantly reduce cancer drug testing and screening time

In a breakthrough for personalised oncology, scientists have developed and demonstrated a novel platform that can significantly reduce the time needed to determine the efficacy of anti-cancer drugs.

Subscribe to Newsletter